Ischemia-reperfusion injury causes oxidative stress and apoptosis of Schwann cell in acute and chronic experimental diabetic neuropathy

Antioxidants and Redox Signaling

Volumn 7, Issue 11-12, 2005, Pages 1513-1520

  Wang, Yanping ^a   Schmeichel, Ann M ^a   Iida, Haruyasu ^a   Schmelzer, James D ^a   Low, Phillip A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CASPASE 3; COBALT; DNA NUCLEOTIDYLEXOTRANSFERASE; PROTEIN S 100;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MALE; NERVE FIBER DEGENERATION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCHWANN CELL; SCIATIC NERVE; STREPTOZOCIN DIABETES; TIBIAL NERVE;

ACUTE DISEASE; AGING; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; CHRONIC DISEASE; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SCHWANN CELLS;

ANIMALIA;

EID: 28844459978     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1513     Document Type: Article

References (38)

1. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, and Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin J Clin Invest 102: 783-791, 1998.
2. Brownlee M, Cerami A, and Vlassara H. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 4: 437-451, 1988.
3. Cai L, Li W, Wang G, Guo L, Jiang Y, and Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51: 1938-1948, 2002.
4. Cameron NE and Cotter MA. Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin- diabetic rats. Acta Diabetol 31: 220-225, 1994.
5. +-ATPase activity and glutathione content in diabetic rats. Diabetologia 42: 1120-1130, 1999.
6. Cheng C and Zochodne DW. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 52: 2363-2371, 2003.
7. Dyck PJ, Windebank A, Yasuda H, Service FJ, Rizza R, and Zimmerman B. Diabetic neuropathy. Adv Exp Med Biol 189: 305-320, 1985.
8. Dyck PJ, Giannini C, and Lais A. Pathologic alterations of nerves. In: Peripheral Neuropathy, edited by Dyck PJ, Thomas PK, Griffin JW, Low PA, and Poduslo JF. Philadelphia: WB Saunders, 1993, pp. 514-595.
9. Dyck PJB, Norell JE, and Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 53: 2113-2121, 1999.
10. Greene DA, Sima AA, Stevens MJ, Feldman EL, and Lattimer SA. Complications: neuropathy, pathogenetic considerations. Diabetes Care 15: 1902-1925, 1992.
11. Hellweg R and Hartung HD. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 26: 258-267, 1990.
12. Kihara M, Zollman PJ, Schmelzer JD, and Low PA. The influence of dose of microspheres on nerve blood flow, electrophysiology, and fiber degeneration of rat peripheral nerve. Muscle Nerve 16: 1383-1389, 1993.
13. Kishi M, Tanabe J, Schmelzer JD, and Low PA. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 51: 819-824, 2002.
14. Li ZG, Zhang W, Grunberger G, and Sima AA. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 946: 221-231, 2002.
15. Low PA and Nickander KK. Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40: 873-877, 1991.
16. Low PA and Tuck RR. Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J Physiol 347: 513-524, 1984.
17. Low PA, Lagerlund TD, and McManis PG. Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol 31: 355-438, 1989.
18. Low PA, Nickander KK, and Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46: S38-S42, 1997.
19. Low PA, Nickander KK, and Scionti L. Role of hypoxia, oxidative stress, and excitatory neurotoxins in diabetic neuropathy. In: Diabetic Neuropathy, edited by Dyck PJ and Thomas PK. Philadelphia: WB Saunders, 1999, pp. 317-329.
20. Mitsui Y, Schmelzer JD, Zollman PJ, Kihara M, and Low PA. Hypothermic neuroprotection of peripheral nerve of rats from ischaemia-reperfusion injury. Brain 122: 161-169, 1999.
21. Mitsui Y, Schmelzer JD, Zollman PJ, Mitsui M, Tritschler HJ, and Low PA. Alpha-lipoic acid provides neuroprotection from ischemia-reperfusion injury of peripheral nerve. J Neurol Sci 163: 11-16, 1999.
22. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, and Low PA. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18: 1160-1167, 1995.
23. Nagamatsu M, Schmelzer ID, Zollman PJ, Smithson IL, Nickander KK, and Low PA. Ischemic reperfusion causes lipid peroxidation and fiber degeneration. Muscle Nerve 19: 37-47, 1996.
24. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
25. Nukada H. Mild ischaemia causes severe pathological changes in experimental diabetic nerve. Muscle Nerve 15: 1116-1122, 1992.
26. Obrosova IG. How does glucose generate oxidative stress in peripheral nerve? Int Rev Neurobiol 50: 3-35, 2002.
27. Obrosova IG, Fathallah L, and Stevens MJ. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp Neurol 172: 211-219, 2001.
28. Romero FJ, Segura-Aguilar J, Monsalve E, Hermenegildo C, Nies E, Puertas FJ, and Roma J. Antioxidant and glutathione-related enzymatic activities in rat sciatic nerve. Neurotoxicol Teratol 12: 603-605, 1990.
29. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, and Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6: 347-363, 1999.
30. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, and Feldman EL. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16: 1738-1748, 2002.
31. Schmeichel AM, Schmelzer JD, and Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52: 165-171, 2003.
32. Schmelzer JD, Zochodne DW, and Low PA. Ischemic and reperftision injury of rat peripheral nerve. Proc Natl Acad Sci U S A 86: 1639-1642, 1989.
33. Srinivasan S, Stevens M, and Wiley JW. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49: 1932-1938, 2000.
34. Takeuchi M and Low PA. Dynamic peripheral nerve metabolic and vascular responses to exsanguination. Am J Physiol 251: E349-E353, 1987.
35. Vincent AM, Brownlee M, and Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann NY Acad Sci 959: 368-383, 2002.
36. Wang Y, Schmelzer JD, Schtneichel AM, Iida H, and Low PA. Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy. J Neurol Sci 227: 101-107, 2004.
37. Yuan J and Yankner BA. Apoptosis in the nervous system. Nature 407: 802-809, 2000.
38. Zochodne DW and Cheng C. Diabetic peripheral nerves are susceptible to multifocal ischemic damage from endothelin. Brain Res 838: 11-17, 1999.